The study was a laboratory experiment with a repeated measures design.
The Wisconsin Card sort test (WCST) was used in the study.
SPECT was used to scan cerebral blood flow.
The Psychiatric Symptoms Assessment scale was used to measure patients' symptoms.
The study involved 10 schizophrenic patients, aged 20-50, from Washington, USA.
A placebo was used as a control to investigate the effects of amphetamine, and was counterbalanced so they received both over two days.